Company profile: Ascend Clinical
1.1 - Company Overview
Company description
- Provider of diagnostic laboratory testing and electronic information delivery for independent dialysis providers, offering a comprehensive testing menu, automated calculations, and specific reference ranges for results and reports to support accurate results and patient care.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Ascend Clinical
SmartLabs
HQ: United States
Website
- Description: Provider of labs and lab operations, building and operating multi-use R&D labs, vivariums, process development, and manufacturing suites.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SmartLabs company profile →
Cyrus
HQ: United States
Website
- Description: Provider of protein design software and services, including the Rosetta software combining physics-based modeling and statistical patterns to design protein binders, de novo proteins, and assemblies; the Cyrus software platform with Rosetta protocols, AI, cloud workflow automation, and in-house structure/data analysis; services for protein design, deep mutational scanning, cytokine engineering; and Next Gen IdeS enzyme for IgG-mediated disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cyrus company profile →
Evozyne
HQ: United States
Website
- Description: Provider of generative AI-driven protein design and engineering solutions for therapeutic discovery and drug development, including ProT-VAE (co-developed with NVIDIA) to design therapeutic proteins, protein engineering for rare diseases (in partnership with Takeda), evolutionary deep learning to create novel proteins, and computational chemistry to optimize protein stability and function.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Evozyne company profile →
Metaphore Bio
HQ: United States
Website
- Description: Provider of the MIMIC™ platform, a bioplatform that integrates machine learning and molecular mimicry to engineer therapeutics targeted at specific biological responses.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Metaphore Bio company profile →
HealthMode
HQ: United States
Website
- Description: Provider of AI-enabled digital measurement methods that increase the precision and speed of clinical research and improve healthcare, driving progression to next-generation clinical trials through the development and delivery of digital measurements for clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HealthMode company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Ascend Clinical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Ascend Clinical
2.2 - Growth funds investing in similar companies to Ascend Clinical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Ascend Clinical
4.2 - Public trading comparable groups for Ascend Clinical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →